1.27 USD
↗ 0.03 (2.42%)PRE MARKET (AS OF 05:13 AM EDT)
Ocugen, Inc. Common Stock
OCGNNASDAQ • USD
Market: OPEN
OCGN is currently priced at $1.27. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 18, 2026.
Open?$1.27
High?$1.28
Low?$1.27
Prev. Close?$1.24
Volume?11.8K
Avg. Volume?6.6M
VWAP?$1.27
Rel. Volume?0.00x
Bid / Ask
Bid?$1.09 × 100
Ask?$1.45 × 100
Spread?$0.36
Midpoint?$1.27
Valuation & Ratios
Market Cap?419.8M
Shares Out?338.5M
Float?322.0M
Float %?95.1%
P/E Ratio?N/A
P/B Ratio?72.31
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Themes
Employees
116
Market Cap
419.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2014-12-03
Address
11 GREAT VALLEY PARKWAY
MALVERN, PA 19355
Phone: 484-328-4701
MALVERN, PA 19355
Phone: 484-328-4701
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?35
Short Sent.?10
Piotroski F-Score?1/9Weak
Altman Z-Score?-7.98Distress
Confidence?68%Moderate
Short InterestSqueeze Risk
Short % of Float?25.78%Squeeze Risk
Short Interest?83.0M
Days to Cover?14.3
Free Float322.0M
Avg Daily Volume5.8M
Settlement Date2026-05-29
Financial Health
Current Ratio?1.86Adequate
Quick Ratio?1.86Adequate
Cash Ratio?1.54Strong
Debt/Equity?5.03High
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?72.31HIGH▾
Peers33
S&P3
P/S?90.12HIGH▾
Peers33
S&P3
P/FCF?N/A▾
EV/EBITDA?-8.8CHEAP▾
Peers100
S&P97
EV/Sales?89.55HIGH▾
Peers33
S&P3
Returns & Efficiency
ROE?-929.7%WEAK▾
Peers50
S&P3
ROA?-94.8%WEAK▾
Peers50
S&P3
Cash Flow & Enterprise
FCF?$-59576000
Enterprise Value?$417.1M
Fundamentals ratios updated end of day